Brief: Reyon Pharmaceutical lowers conversion price of 1st series convertible bonds to 21,296 won/share
30/11/2017 09:30
Nov 30 (Reuters) - Reyon Pharmaceutical Co Ltd 102460.KS :
* Says it lowered conversion price of 1st series convertible
bonds to 21,296 won/share from 27,685 won/share, effective Nov.
30
Source text in Korean: https://goo.gl/Lxiqyq
Further company coverage: 102460.KS
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: hedy.cui.reuters.com@reuters.net))
Recent news on Reyon Pharmaceutical Co
See all newsBrief: Reyon Pharmaceutical to pay cash dividend at 350 won/share
Brief: Reyon Pharmaceutical lowers conversion price of 1st series convertible bonds to 21,296 won/share
Brief: Reyon Pharmaceutical announces issuance of 3.9 mln bonus shares
Brief: Reyon Pharmaceutical to buy new technology financing firm for 10 bln won
Brief: Reyon Pharmaceutical to invest 80 bln won to set up gene medicine factory